FDA Approved: QULIPTA — Original Application (AbbVie Inc.)

View source ↗

Summary

The FDA approved QULIPTA (atogepant) from AbbVie in its original NDA for the preventive treatment of migraine in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Qulipta (atogepant)

Snippet

ORIG AP for QULIPTA (ATOGEPANT)